Communicating Across Cultures – Applying What We Know About Culture

The fourth and final virtual event in the Communicating Across Cultures series featured a look into communication and culture inside BioMarin Pharmaceuticals. This discussion was led by James O’Rourke, a professor in the Mendoza College of Business, with guest speaker, Debra Charlesworth ‘90, VP of Corporate Communications, BioMarin Pharmaceuticals, and moderated by Amanda McKendree, professor in the Mendoza College of Business. This event explored BioMarin’s organizational culture, approaches to communication and diversity, as well as where BioMarin is headed for the future. Charlesworth joined BioMarin in 2012 and is responsible for developing corporate communications strategy to support corporate goals.  She works closely with the executive team to raise BioMarin’s profile as a scientific leader in developing therapies for patients with rare genetic diseases.

The conversation kicked off by discussing how Charlesworth defines culture at BioMarin. Charlesworth noted that the definition of culture could be different for various employees, but she believed a core part of BioMarin’s culture is its patient focus. Since BioMarin’s patient population is small, they have a privilege to really get to know their patients. O’Rourke asked Charlesworth if BioMarin takes time to define and measure the organizational culture. Charlesworth believed that the more the company grows, the more vital it will be to define culture. As BioMarin scales up in size and employees, Charlesworth thinks that having a defined culture will ultimately help the company preserve its meaning. When BioMarin hires new employees, they look for four specific attributes in the candidate which helps them find the right fit. These attributes include good decision making skills, influence, agility, and leadership.

O’Rourke shifted the conversation into one about diversity and inclusion. Charlesworth believes BioMarin has a strong foundation in diversity and inclusion, especially because their target focus is on rare diseases. Rare diseases, she considers, are like a minority group amongst other pharmaceutical research. BioMarin has also brought in consultancies who’ve helped build their diversity efforts. They’ve created employee resource groups and diversity circles with direct lines of communication to executive leadership, which fosters and encourages difficult conversation within the company around diversity, equity, and inclusion. The company also looks each year to make sure salaries and training programs are competitive against peer organizations.

The conversation concluded with a discussion about where BioMarin is headed in the future in terms of their corporate communication team. Charlesworth described her communications team of four people as small, but mighty. In the future, she hopes to scale up this team and add more employees because compared to other organizations, they are on the lower end of the spectrum as a corporate communications team. Scaling up will allow BioMarin to become more effective in their communications and will help grow their reach and influence. 

Visit the event page for more.